KYMR - Company ID 0001815442
As of 2026-11-06, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $10.74 B, making it the #890 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $10.74 B |
| 2026-11-05 | $10.36 B |
| 2026-11-04 | $11.22 B |
| 2026-11-03 | $10.45 B |
| 2026-11-02 | $10.52 B |
| 2026-11-01 | $10.42 B |
| 2026-10-31 | $10.42 B |
| 2026-10-30 | $10.29 B |
| 2026-10-29 | $10.04 B |
| 2026-10-28 | $10.08 B |
| 2026-10-27 | $9.67 B |
| 2026-10-26 | $9.45 B |
As of 2026-11-06, Kymera Therapeutics, Inc. (KYMR) has a market capitalization of $10.74 B, making it the #890 most valuable US-listed company.
Kymera Therapeutics, Inc. is the #890 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $9.11 B |
| 2026-10-24 | $9.11 B |
| 2026-10-23 | $9.13 B |
| 2026-10-22 | $9.12 B |
| 2026-10-21 | $9.47 B |
| 2026-10-20 | $9.36 B |
| 2026-10-19 | $8.89 B |
| 2026-10-18 | $8.62 B |
| 2026-10-17 | $8.62 B |
| 2026-10-16 | $8.67 B |
| 2026-10-15 | $8.90 B |
| 2026-10-14 | $8.79 B |
| 2026-10-13 | $8.87 B |
| 2026-10-12 | $9.14 B |
| 2026-10-11 | $9.25 B |
| 2026-10-10 | $9.25 B |
| 2026-10-09 | $9.25 B |
| 2026-10-08 | $8.99 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.